Status:
UNKNOWN
Ergospirometry in Paroxysmal Atrial Fibrillation Prognosis
Lead Sponsor:
Aristotle University Of Thessaloniki
Collaborating Sponsors:
General Hospital Of Thessaloniki Ippokratio
Conditions:
Atrial Fibrillation
Atrial Arrhythmia
Eligibility:
All Genders
18+ years
Brief Summary
An observational, prospective, cohort study aiming to assess the potential predictive role of cardiopulmonary exercise testing in the prognosis of paroxysmal atrial fibrillation, in combination with e...
Detailed Description
The "ParoxysmaL Atrial fibrillation prognosis based on Cardiopulmonary Exercise test data and novel echocardiographic and plasma BiOchemical indices" (PLACEBO) trial comprises an observational, prospe...
Eligibility Criteria
Inclusion
- Patients with paroxysmal atrial fibrillation (in sinus rhythm during baseline evaluation)
- Age \> 18 years
- Capability of providing written consent
- Patients able to undergo cardiopulmonary exercise testing
- Patients able to comply with the follow-up schedule of the study
Exclusion
- Patients with structural cardiomyopathy
- Patients with congenital heart disease
- Patients with permanent atrial fibrillation
- Patients who have undergone atrial fibrillation ablation
- Patients with implanted cardiac devices for primary or secondary prevention
- Patients with recent (within the last month) acute coronary syndrome
- Patients with heart failure with reduced ejection fraction (HFrEF) or end-stage renal disease
- Patients with autoimmune diseases or active malignancies
- Patients with uncontrolled thyroid disease
- Patients unable to undergo cardiopulmonary exercise testing due to disability or motility issues
- Patients who present with contraindications for cardiopulmonary exercise testing
- Patients unable to provide written consent
- Patients with poor echocardiographic images
- Patients unable to undergo spirometry
- Patients unable to comply with the follow-up schedule of the study
- Patients with uncontrolled hypertension
- Patients who have undergone recent (within the last 2 months) surgery
- Pregnancy
Key Trial Info
Start Date :
December 10 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 10 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05246423
Start Date
December 10 2020
End Date
December 10 2024
Last Update
February 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ippokratio General Hospital
Thessaloniki, Thessaloniki, Greece, 54642